337 related articles for article (PubMed ID: 17999358)
41. Translation of SOX10 3' untranslated region causes a complex severe neurocristopathy by generation of a deleterious functional domain.
Inoue K; Ohyama T; Sakuragi Y; Yamamoto R; Inoue NA; Yu LH; Goto Y; Wegner M; Lupski JR
Hum Mol Genet; 2007 Dec; 16(24):3037-46. PubMed ID: 17855451
[TBL] [Abstract][Full Text] [Related]
42. A de novo SOX10 mutation causing severe type 4 Waardenburg syndrome without Hirschsprung disease.
Sznajer Y; Coldéa C; Meire F; Delpierre I; Sekhara T; Touraine RL
Am J Med Genet A; 2008 Apr; 146A(8):1038-41. PubMed ID: 18348267
[TBL] [Abstract][Full Text] [Related]
43. Familial co-segregation of Coffin-Lowry syndrome inherited from the mother and autosomal dominant Waardenburg type IV syndrome due to deletion of EDNRB inherited from the father.
Loupe J; Sampath S; Lacassie Y
Eur J Med Genet; 2014 Oct; 57(10):562-6. PubMed ID: 25118007
[TBL] [Abstract][Full Text] [Related]
44. A Novel Spontaneous Mutation of the
Chen S; Jin Y; Xie L; Xie W; Xu K; Qiu Y; Bai X; Zhang HM; Liu XZ; Wang XH; Kong WJ; Sun Y
Neural Plast; 2020; 2020():9260807. PubMed ID: 32908492
[TBL] [Abstract][Full Text] [Related]
45. EDNRB mutations cause Waardenburg syndrome type II in the heterozygous state.
Issa S; Bondurand N; Faubert E; Poisson S; Lecerf L; Nitschke P; Deggouj N; Loundon N; Jonard L; David A; Sznajer Y; Blanchet P; Marlin S; Pingault V
Hum Mutat; 2017 May; 38(5):581-593. PubMed ID: 28236341
[TBL] [Abstract][Full Text] [Related]
46. Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3.
Potterf SB; Furumura M; Dunn KJ; Arnheiter H; Pavan WJ
Hum Genet; 2000 Jul; 107(1):1-6. PubMed ID: 10982026
[TBL] [Abstract][Full Text] [Related]
47. An impairment of long distance SOX10 regulatory elements underlies isolated Hirschsprung disease.
Lecerf L; Kavo A; Ruiz-Ferrer M; Baral V; Watanabe Y; Chaoui A; Pingault V; Borrego S; Bondurand N
Hum Mutat; 2014 Mar; 35(3):303-7. PubMed ID: 24357527
[TBL] [Abstract][Full Text] [Related]
48. A de novo deletion mutation in SOX10 in a Chinese family with Waardenburg syndrome type 4.
Wang X; Zhu Y; Shen N; Peng J; Wang C; Liu H; Lu Y
Sci Rep; 2017 Jan; 7():41513. PubMed ID: 28128317
[TBL] [Abstract][Full Text] [Related]
49. A patient with peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and severe hypoganglionosis associated with a novel SOX10 mutation.
Akutsu Y; Shirai K; Takei A; Goto Y; Aoyama T; Watanabe A; Imamura M; Enokizono T; Ohto T; Hori T; Suzuki K; Hayashi M; Masumoto K; Inoue K
Am J Med Genet A; 2018 May; 176(5):1195-1199. PubMed ID: 29681101
[TBL] [Abstract][Full Text] [Related]
50. Neurological Waardenburg-Shah syndrome: a diagnostic challenge in a child with skin hypopigmentation and neurological manifestation.
Ng BW; Lee JS; Toh TH; Ngu LH
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35725288
[TBL] [Abstract][Full Text] [Related]
51. Novel mutations in the SOX10 gene in the first two Chinese cases of type IV Waardenburg syndrome.
Jiang L; Chen H; Jiang W; Hu Z; Mei L; Xue J; He C; Liu Y; Xia K; Feng Y
Biochem Biophys Res Commun; 2011 May; 408(4):620-4. PubMed ID: 21531202
[TBL] [Abstract][Full Text] [Related]
52. Alu-mediated deletion of SOX10 regulatory elements in Waardenburg syndrome type 4.
Bondurand N; Fouquet V; Baral V; Lecerf L; Loundon N; Goossens M; Duriez B; Labrune P; Pingault V
Eur J Hum Genet; 2012 Sep; 20(9):990-4. PubMed ID: 22378281
[TBL] [Abstract][Full Text] [Related]
53. Chromosome 13q deletion with Waardenburg syndrome: further evidence for a gene involved in neural crest function on 13q.
Van Camp G; Van Thienen MN; Handig I; Van Roy B; Rao VS; Milunsky A; Read AP; Baldwin CT; Farrer LA; Bonduelle M
J Med Genet; 1995 Jul; 32(7):531-6. PubMed ID: 7562965
[TBL] [Abstract][Full Text] [Related]
54. A novel case of concurrent occurrence of demyelinating-polyneuropathy-causing PMP22 duplication and SOX10 gene mutation producing severe hypertrophic neuropathy.
Matsuda N; Ootsuki K; Kobayashi S; Nemoto A; Kubo H; Usami SI; Kanani K
BMC Neurol; 2021 Jun; 21(1):243. PubMed ID: 34171997
[TBL] [Abstract][Full Text] [Related]
55. Kallmann Syndrome Due to Heterozygous Mutation in
Chen K; Wang H; Lai Y
Front Endocrinol (Lausanne); 2020; 11():592831. PubMed ID: 33597923
[TBL] [Abstract][Full Text] [Related]
56. Clinical manifestations and novel pathogenic variants in SOX10 in eight Danish probands with Waardenburg syndrome.
Moldenæs MF; Rendtorff ND; Hindbæk LS; Tørring PM; Nilssen Ø; Tranebjærg L
Eur J Med Genet; 2021 Sep; 64(9):104265. PubMed ID: 34171448
[TBL] [Abstract][Full Text] [Related]
57. Deletion of long-range sequences at Sox10 compromises developmental expression in a mouse model of Waardenburg-Shah (WS4) syndrome.
Antonellis A; Bennett WR; Menheniott TR; Prasad AB; Lee-Lin SQ; ; Green ED; Paisley D; Kelsh RN; Pavan WJ; Ward A
Hum Mol Genet; 2006 Jan; 15(2):259-71. PubMed ID: 16330480
[TBL] [Abstract][Full Text] [Related]
58. A heterozygous endothelin 3 mutation in Waardenburg-Hirschsprung disease: is there a dosage effect of EDN3/EDNRB gene mutations on neurocristopathy phenotypes?
Pingault V; Bondurand N; Lemort N; Sancandi M; Ceccherini I; Hugot JP; Jouk PS; Goossens M
J Med Genet; 2001 Mar; 38(3):205-9. PubMed ID: 11303518
[No Abstract] [Full Text] [Related]
59. Novel mutations of SOX10 suggest a dominant negative role in Waardenburg-Shah syndrome.
Sham MH; Lui VC; Chen BL; Fu M; Tam PK
J Med Genet; 2001 Sep; 38(9):E30. PubMed ID: 11546831
[No Abstract] [Full Text] [Related]
60. Clinical variability of Waardenburg-Shah syndrome in patients with proximal 13q deletion syndrome including the endothelin-B receptor locus.
Tüysüz B; Collin A; Arapoğlu M; Suyugül N
Am J Med Genet A; 2009 Oct; 149A(10):2290-5. PubMed ID: 19764031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
